Proceedings of the National Academy of Sciences · 2018 · 56 citations · 15 references
MedicineCancer BiologyMolecular BiologyCell SignalingEpigeneticsSignal TransductionCancer Cell SignalingCancer EpigeneticsEpigenetic Regulation In CancerHistone ModificationsOncogenic Signaling PathwaysSignal Transduction In CancerCancer Signaling PathwaysCovalent Histone ModificationsEpigenetic ControlHistone DemethylasesJak-stat Signaling PathwayProtein Tyrosine PhosphorylationStat3 SignalingTherapeutic Target Identification
Janus tyrosine kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling pathway is essential for modulating cellular development, differentiation, and homeostasis. Thus, dysregulation of JAK2-STAT3 signaling pathway is frequently associated with human malignancies. Here, we provide evidence that lysine-specific demethylase 3A (KDM3A) functions as an essential epigenetic enzyme for the activation of JAK2-STAT3 signaling pathway. KDM3A is tyrosine-phosphorylated by JAK2 in the nucleus and functions as a STAT3-dependent transcriptional coactivator. JAK2-KDM3A signaling cascade induced by IL-6 leads to alteration of histone H3K9 methylation as a predominant epigenetic event, thereby providing the functional and mechanistic link between activation of JAK2-STAT3 signaling pathway and its epigenetic control. Together, our findings demonstrate that inhibition of KDM3A phosphorylation could be a potent therapeutic strategy to control oncogenic effect of JAK2-STAT3 signaling pathway.
15
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Evan Parganas, Demin Wang, Dimitrios J. Stravopodis et al. · Cell · 1998 · 1.2K citations · Full text